Literature DB >> 24376927

Differential dose contributions on total dose distribution of (125)I brachytherapy source.

B Camgöz1, G Yeğin2, M N Kumru1.   

Abstract

This work provides an improvement of the approach using Monte Carlo simulation for the Amersham Model 6711 (125)I brachytherapy seed source, which is well known by many theoretical and experimental studies. The source which has simple geometry was researched with respect to criteria of AAPM Tg-43 Report. The approach offered by this study involves determination of differential dose contributions that come from virtual partitions of a massive radioactive element of the studied source to a total dose at analytical calculation point. Some brachytherapy seeds contain multi-radioactive elements so the dose at any point is a total of separate doses from each element. It is momentous to know well the angular and radial dose distributions around the source that is located in cancerous tissue for clinical treatments. Interior geometry of a source is effective on dose characteristics of a distribution. Dose information of inner geometrical structure of a brachytherapy source cannot be acquired by experimental methods because of limits of physical material and geometry in the healthy tissue, so Monte Carlo simulation is a required approach of the study. EGSnrc Monte Carlo simulation software was used. In the design of a simulation, the radioactive source was divided into 10 rings, partitioned but not separate from each other. All differential sources were simulated for dose calculation, and the shape of dose distribution was determined comparatively distribution of a single-complete source. In this work anisotropy function was examined also mathematically.

Entities:  

Keywords:  Brachytherapy; Monte Carlo; Radiation dose

Year:  2010        PMID: 24376927      PMCID: PMC3863301          DOI: 10.1016/j.rpor.2010.04.003

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  8 in total

1.  Radial dose functions for 103Pd, 125I, 169Yb and 192Ir brachytherapy sources: an EGS4 Monte Carlo study.

Authors:  E Mainegra; R Capote; E López
Journal:  Phys Med Biol       Date:  2000-03       Impact factor: 3.609

2.  Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64.

Authors:  Y Yu; L L Anderson; Z Li; D E Mellenberg; R Nath; M C Schell; F M Waterman; A Wu; J C Blasko
Journal:  Med Phys       Date:  1999-10       Impact factor: 4.071

3.  Dosimetric characteristics of the DRAXIMAGE model LS-1 1-125 interstitial brachytherapy source design: a Monte Carlo investigation.

Authors:  Jeffrey F Williamson
Journal:  Med Phys       Date:  2002-04       Impact factor: 4.071

4.  Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.

Authors:  Mark J Rivard; Bert M Coursey; Larry A DeWerd; William F Hanson; M Saiful Huq; Geoffrey S Ibbott; Michael G Mitch; Ravinder Nath; Jeffrey F Williamson
Journal:  Med Phys       Date:  2004-03       Impact factor: 4.071

5.  Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver.

Authors:  R Martinez-Monge; S Nag; C A Nieroda; E W Martin
Journal:  Cancer       Date:  1999-03-15       Impact factor: 6.860

6.  Dosimetric and technical aspects of intraoperative I-125 brachytherapy for stage I non-small cell lung cancer.

Authors:  Mark Johnson; Athanasios Colonias; David Parda; Mark Trombetta; Olivier Gayou; Bodo Reitz; Moyed Miften
Journal:  Phys Med Biol       Date:  2007-01-31       Impact factor: 3.609

7.  Dosimetric characterization of a newly designed encapsulated interstitial brachytherapy source of iodine-125-model LS-1 BrachySeed.

Authors:  R Nath; N Yue
Journal:  Appl Radiat Isot       Date:  2001-12       Impact factor: 1.513

8.  The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society.

Authors:  C J Mettlin; G P Murphy; D S Rosenthal; H R Menck
Journal:  Cancer       Date:  1998-10-15       Impact factor: 6.860

  8 in total
  2 in total

1.  Recent developments in brachytherapy.

Authors:  Ferran Guedea
Journal:  Rep Pract Oncol Radiother       Date:  2011-12-04

2.  A Monte Carlo evaluation for effects of probable dimensional uncertainties of low dose rate brachytherapy seeds on dose.

Authors:  Berkay Camgöz; Mehmet N Kumru
Journal:  Rep Pract Oncol Radiother       Date:  2014-07-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.